Who are MoonLake's main competitors or similar companies to consider before investing?

When looking at MoonLake, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors: Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex VRTX 114.06B Healthcare Biotechnology -6.00% 56.88% Regeneron REGN 55.27B Healthcare Biotechnology -51.08% -11.43% Blueprint Medicines BPMC 8.29B Healthcare Biotechnology 9.02% 139.78% Roivant Sciences ROIV 7.82B Healthcare Biotechnology -5.37% 151.52% Bio-Techne TECH 7.92B Healthcare Biotechnology -33.33% -40.13% For a more comprehensive list, please see the Peer Performance Comparison table on this page.

MoonLake (MLTX) | Stock Overview & Key Data

MoonLake Immunotherapeutics | Mid-cap | Healthcare

$46.75

-1.58%

| MoonLake Stock Comparison:

MoonLake vs Vertex MoonLake vs Regeneron MoonLake vs Blueprint Medicines MoonLake vs Roivant Sciences MoonLake vs Bio-Techne MoonLake vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

MoonLake Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	MoonLake	Healthcare Sector	S&P 500
1 Week	0.30%	N/A	N/A
1 Month	0.28%	N/A	N/A
3 Months	42.40%	N/A	N/A
1 Year	2.37%	N/A	N/A

MoonLake

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $46.37 High: $47.85

on July 8, 2025

52 Week Range

Low: $31.42 High: $58.26

on April 9, 2025

on December 17, 2024

All-Time High: $64.98 on February 12, 2024

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $2.8B

EPS i -2.30

P/E Ratio (TTM) i -24.21

Forward P/E i -17.33

P/B Ratio i 6.78

PEG Ratio i -17.33

Div. Yield i N/A

ROE i -30.64%

Beta i 1.230

Debt to Equity i 18.32

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -19.85%

Return on Equity (TTM) i -30.64%

EBITDA i $-169.3M

Net Income (TTM) i $-145.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i N/A

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
MoonLake MLTX	2.76B Mid-cap	0.30%	0.28%	42.40%	-2.95%	-12.73%	2.37%	709.20%	349.81%
Vertex VRTX	114.06B Large-cap	3.14%	4.53%	-1.27%	13.16%	14.93%	-6.00%	56.88%	55.98%
Regeneron REGN	55.27B Large-cap	2.40%	5.82%	-1.63%	-25.33%	-23.41%	-51.08%	-11.43%	-16.45%
Blueprint Medicines BPMC	8.29B Mid-cap	0.05%	0.34%	62.08%	41.67%	47.25%	9.02%	139.78%	65.31%
Roivant Sciences ROIV	7.82B Mid-cap	-0.73%	-1.99%	19.60%	-1.45%	-10.10%	-5.37%	151.52%	8.27%
Bio-Techne TECH	7.92B Mid-cap	1.15%	5.61%	7.93%	-29.94%	-26.30%	-33.33%	-40.13%	-26.31%

Ownership & Short Interest

Insider Ownership i 15.34%

Institutional Ownership i 96.92%

Shares Short i 6M

Short Ratio i 20.27

Short % of Shares Outstanding i 22.32%

Average 10-Day Volume i 479K

Average 90-Day Volume i 564K

MoonLake Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in MoonLake would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of MoonLake, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: 0.30%
1 Month: 0.28%
3 Months: 42.40%
1 Year: 2.37%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, MoonLake reached a high of $58.26 (on December 17, 2024) and a low of $31.42 (on April 9, 2025).

Curious about MoonLake's size and valuation? Its market capitalization stands at 2.76B. When it comes to valuation, the P/E ratio (trailing twelve months) is -24.21, and the forward P/E (looking ahead) is -17.33.

As for dividends, MoonLake isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at MoonLake, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	114.06B	Healthcare	Biotechnology	-6.00%	56.88%
Regeneron REGN	55.27B	Healthcare	Biotechnology	-51.08%	-11.43%
Blueprint Medicines BPMC	8.29B	Healthcare	Biotechnology	9.02%	139.78%
Roivant Sciences ROIV	7.82B	Healthcare	Biotechnology	-5.37%	151.52%
Bio-Techne TECH	7.92B	Healthcare	Biotechnology	-33.33%	-40.13%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of MoonLake's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -30.64%, the Debt to Equity ratio from the most recent quarter is 18.32, and its Gross Profit Margin stands at N/A.

Looking at MoonLake's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

Wondering who owns MoonLake stock? Company insiders (like executives and directors) hold about 15.34% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.92%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.